Literature DB >> 33011441

Comparison of Pathogenicity Prediction Tools on Somatic Variants.

Voreak Suybeng1, Florence Koeppel2, Alexandre Harlé3, Etienne Rouleau4.   

Abstract

Genomic sequencing is increasingly used in managing patients with cancer. Interpretation of somatic variants and their pathogenicity is often complex. Pathogenicity prediction tools are commonly used as part of the expert interpretation of somatic variants, but most of these tools were initially developed for germline variants. Our aim was to benchmark their performance for somatic variants. A gold standard list was assembled of 4319 somatic single-nucleotide variants, classified as oncogenic (n = 2996) or neutral (n = 1323), based on their presence in curated databases or on their allele frequency in the general population. These variants were annotated with the most commonly used prediction tools [Database for Nonsynonymous SNPs' Functional Predictions (dbNSFP) and Universal Mutation Database Predictor (UMD-Predictor)] and computed performance calculations. Stratification of the prediction tools based on Matthews correlation coefficient and area under the receiver operating characteristic curve allowed the identification of the top-performing ones, namely, Combined Annotation-Dependent Depletion (CADD), Eigen or Eigen Principal Components (Eigen-PC), Polymorphism Phenotyping version 2 (PolyPhen-2), Protein Variation Effect Analyzer (PROVEAN), UMD-Predictor, and Rare Exome Variant Ensemble Learner (REVEL). Interestingly, Sorting Intolerant From Tolerant (SIFT), which is a commonly used prediction tool for somatic variants, was ranked in the second performance category. Combining tools two by two only marginally improved performances, mainly because of the occurrence of discordant predictions.
Copyright © 2020 Association for Molecular Pathology and American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 33011441     DOI: 10.1016/j.jmoldx.2020.08.007

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  8 in total

1.  Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnostics.

Authors:  Kenneth D Doig; Christopher G Love; Thomas Conway; Andrei Seleznev; David Ma; Andrew Fellowes; Piers Blombery; Stephen B Fox
Journal:  BMC Med Genomics       Date:  2022-03-26       Impact factor: 3.063

Review 2.  Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner.

Authors:  Christophe Bontoux; Véronique Hofman; Patrick Brest; Marius Ilié; Baharia Mograbi; Paul Hofman
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

Review 3.  Genome interpretation using in silico predictors of variant impact.

Authors:  Panagiotis Katsonis; Kevin Wilhelm; Amanda Williams; Olivier Lichtarge
Journal:  Hum Genet       Date:  2022-04-30       Impact factor: 5.881

4.  Systematic Functional Analysis of PINK1 and PRKN Coding Variants.

Authors:  Benjamin J Broadway; Paige K Boneski; Jenny M Bredenberg; Ana Kolicheski; Xu Hou; Alexandra I Soto-Beasley; Owen A Ross; Wolfdieter Springer; Fabienne C Fiesel
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

5.  RNA-SSNV: A Reliable Somatic Single Nucleotide Variant Identification Framework for Bulk RNA-Seq Data.

Authors:  Qihan Long; Yangyang Yuan; Miaoxin Li
Journal:  Front Genet       Date:  2022-06-30       Impact factor: 4.772

6.  A Comprehensive Evaluation of the Performance of Prediction Algorithms on Clinically Relevant Missense Variants.

Authors:  Erda Qorri; Bertalan Takács; Alexandra Gráf; Márton Zsolt Enyedi; Lajos Pintér; Ernő Kiss; Lajos Haracska
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

Review 7.  Computational approaches for predicting variant impact: An overview from resources, principles to applications.

Authors:  Ye Liu; William S B Yeung; Philip C N Chiu; Dandan Cao
Journal:  Front Genet       Date:  2022-09-29       Impact factor: 4.772

8.  PPFIA4 mutation: A second hit in POLG related disease?

Authors:  Jo Sourbron; Katrien Jansen; Nele Aerts; Lieven Lagae
Journal:  Epilepsy Behav Rep       Date:  2021-05-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.